Ultragenyx Pharmaceutical reported $28.37M in Trade Debtors for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Acadia Pharmaceuticals ACAD:US $ 63.48M 1.86M
Agios Pharmaceuticals AGIO:US $ 5.9M 1.53M
Alnylam Pharmaceuticals ALNY:US $ 156.53M 42.04M
Biocryst Pharmaceuticals BCRX:US $ 36.42M 7M
Biomarin Pharmaceutical BMRN:US $ 430.15M 56.75M
Epizyme EPZM:US $ 5.9M 670K
Esperion Therapeutics ESPR:US 25.12M 2.18M
Insmed INSM:US $ 25.72M 1.37M
Karyopharm Therapeutics KPTI:US $ 24.99M 2.5M
Kyowa Hakko Kirin 4151:JP Y 95561M 8714M
Macrogenics MGNX:US $ 14.9M 4.52M
Mirati Therapeutics MRTX:US $ 1.81M 0.7M
Moderna Inc MRNA:US 3.36B 68M
Ptc Therapeutics PTCT:US $ 141.29M 30.83M
Puma Biotechnology PBYI:US $ 27.04M 5.49M
Regeneron Pharmaceuticals REGN:US $ 4839M 1197.5M
Sarepta Therapeutics SRPT:US $ 197.2M 25.56M
Ultragenyx Pharmaceutical RARE:US $ 28.37M 0.06M
Vertex Pharmaceuticals VRTX:US $ 1292.8M 156M
Vital Therapies VTL:US $ 0.58M 0.31M
Xoma XOMA:US $ 25K 184K